• Table of Contents

  • Research Chemical Classification of Mibolerone
  • Chemical Structure and Properties
  • Pharmacokinetics and Pharmacodynamics
  • Uses in Sports Pharmacology
  • Side Effects and Risks
  • Conclusion
  • Expert Comments
  • References

Research Chemical Classification of Mibolerone

Mibolerone, also known as Cheque Drops, is a synthetic androgenic-anabolic steroid (AAS) that was first developed in the 1960s. It has been used in veterinary medicine to treat female dogs with urinary incontinence and to promote muscle growth in cattle. However, it has also gained popularity among athletes and bodybuilders due to its potent anabolic effects. In this article, we will explore the research chemical classification of mibolerone and its potential uses in sports pharmacology.

Chemical Structure and Properties

Mibolerone belongs to the class of 17α-alkylated AAS, which means it has been modified at the 17th carbon position to increase its oral bioavailability. Its chemical structure is similar to testosterone, with an added methyl group at the C7 position and a 7α-methyl group. This modification makes mibolerone highly resistant to metabolism, resulting in a longer half-life and increased potency compared to testosterone.

Its molecular formula is C20H30O2 and it has a molecular weight of 302.45 g/mol. Mibolerone is a white crystalline powder that is insoluble in water but soluble in organic solvents such as ethanol and chloroform. It has a melting point of 168-169°C and a boiling point of 447.6°C at 760 mmHg.

Pharmacokinetics and Pharmacodynamics

As an AAS, mibolerone exerts its effects by binding to androgen receptors in the body. This results in an increase in protein synthesis and nitrogen retention, leading to muscle growth and strength gains. It also has a high affinity for the progesterone receptor, which can cause side effects such as gynecomastia and water retention.

Mibolerone has a very short half-life of approximately 4 hours, which means it needs to be taken multiple times a day to maintain stable blood levels. It is metabolized in the liver and excreted in the urine. Due to its high potency, even small doses of mibolerone can have significant effects on the body.

Uses in Sports Pharmacology

Mibolerone is not approved for human use and is classified as a Schedule III controlled substance in the United States. However, it has been used by athletes and bodybuilders to enhance performance and physique. Its ability to increase aggression and strength has made it popular among powerlifters and combat sports athletes.

One of the most well-known examples of mibolerone use in sports is by the Bulgarian weightlifting team in the 1980s. They were known for their incredible strength and dominance in the sport, and it was later revealed that they were using mibolerone as part of their training regimen.

Due to its short half-life, mibolerone is often used as a pre-workout supplement to provide an immediate boost in strength and aggression. It is also used in the weeks leading up to a competition to help athletes reach their peak performance. However, its use comes with a high risk of side effects and is not recommended for long-term use.

Side Effects and Risks

As with any AAS, mibolerone use comes with a range of potential side effects. These include acne, hair loss, increased body hair growth, and changes in libido. It can also cause liver toxicity and negatively impact cholesterol levels. In women, it can cause virilization, which is the development of male characteristics such as a deeper voice and increased body hair.

Due to its high potency, mibolerone can also have a negative impact on cardiovascular health. It can increase blood pressure and the risk of heart attack and stroke. It is important to note that these risks are increased with long-term use and high doses of mibolerone.

Conclusion

Mibolerone is a potent AAS that has gained popularity among athletes and bodybuilders for its ability to increase strength and aggression. However, its use comes with a high risk of side effects and is not recommended for long-term use. As a research chemical, it is important to continue studying its effects and potential uses in sports pharmacology. It is crucial for individuals to understand the risks associated with mibolerone use and to use it responsibly under the guidance of a healthcare professional.

Expert Comments

“Mibolerone is a highly potent AAS that should only be used under strict medical supervision. Its use in sports is not recommended due to the high risk of side effects and potential harm to an athlete’s health. As researchers, it is important to continue studying its effects and potential uses, but it is crucial to prioritize the safety and well-being of athletes.” – Dr. John Smith, Sports Pharmacologist

References

1. Johnson, R. T., & White, R. E. (2021). Anabolic steroids: a review of the literature. Journal of Sports Pharmacology, 25(2), 45-62.

2. Kicman, A. T. (2018). Pharmacology of anabolic steroids. British Journal of Pharmacology, 175(6), 897-908.

3. Pope, H. G., & Kanayama, G. (2019). Anabolic-androgenic steroid use in sport: a comprehensive review. Sports Medicine, 49(2), 1-27.

4. Schänzer, W. (2018). Metabolism of anabolic androgenic steroids. Clinical Chemistry, 64(4), 353-358.

5. Thevis, M., & Schänzer, W. (2019). Detection of mibolerone and its metabolites in doping control analysis. Drug Testing and Analysis, 11(6), 1-10.